A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
This study is ongoing, but not recruiting participants.
Study NCT00571675
Information provided by Ascenta Therapeutics
First Received: December 11, 2007
Last Updated: October 30, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
